Anthem Biosciences Limited (NSE:ANTHEM)
India · Delayed Price · Currency is INR 940.65
-1.65 (-0.18%)
Sep 11, 2026, 3:29 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 529.91 billion as of September 11, 2026. Its market cap has increased by 15.75% in one year.
Market Cap
529.91B
Enterprise Value
521.06B
Revenue
20.07B
Ranking
n/a
PE Ratio
93.09
Stock Price
940.65
ChartMarket Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 529.91B, an increase of 29.19%. That is a compound annual growth rate of 25.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 529.91B | 44.83% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biocon | 639.71B |
| OneSource Specialty Pharma | 175.42B |
| Concord Biotech | 153.21B |
| Blue Jet Healthcare | 108.89B |
| Supriya Lifescience | 73.69B |
| Zota Health Care | 38.59B |
| Dishman Carbogen Amcis | 27.28B |
| Panacea Biotec | 24.00B |